Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Philippe Monteyne"'
Autor:
Philippe Monteyne, Pascal Mettens
Publikováno v:
British Medical Bulletin. 62:175-186
Multiple immunotherapy approaches are under development to treat various chronic diseases or conditions. Thanks to dramatic technological improvements, the field of vaccinology can now extend from prophylaxis to therapy, and from infectious diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142e83ea3dd65e14a5d793dea33ed923
https://doi.org/10.1093/bmb/62.1.175
https://doi.org/10.1093/bmb/62.1.175
Publikováno v:
Immunological Reviews. 159:163-176
Theiler's virus is a picornavirus of mouse which causes an acute encephalomyelitis followed by a persistent infection of the white matter of the spinal cord with chronic inflammation and demyelination. This late disease is studied as a model for mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5346f791bfdc22b56abe84e748d6ff47
https://doi.org/10.1111/j.1600-065x.1997.tb01014.x
https://doi.org/10.1111/j.1600-065x.1997.tb01014.x
Autor:
Sharn Ramaya, Philippe Monteyne, Paul V. Barnett, Pascal Mettens, Ralph Biemans, Ghazaleh Pashmi, Remi Palmantier, Jennifer L. Oliver, Timothy Gallagher, Susan Wonnacott
Publikováno v:
Vaccine. 25(42)
Nicotine replacement therapies (NRT) have limited success in smoking cessation. The efficacy of nicotine may be compromised by its main metabolite, cotinine. An anti-cotinine vaccine to remove this antagonism could enhance the efficacy of NRT. We sho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51df565351526578c86b8b0f43df1890
https://pubmed.ncbi.nlm.nih.gov/17870213
https://pubmed.ncbi.nlm.nih.gov/17870213
Autor:
Philippe Monteyne, Francis E. André
Publikováno v:
Vaccine. 18(19)
After the publication of case reports of hepatitis B vaccinees with onset or relapse of multiple sclerosis (MS), followed by a media-driven scare campaign in France, the perception that hepatitis B vaccine causes MS has developed. This has led to a f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6b6c1ed27f088f082a991b184cadeb4
https://pubmed.ncbi.nlm.nih.gov/10706960
https://pubmed.ncbi.nlm.nih.gov/10706960
Autor:
Jean-François Bureau, Philippe Monteyne, Stéphanie Aubagnac, Arièle Azoulay-Cayla, Franck Bihl
Publikováno v:
Annales de l'Institut Pasteur/Actualités
Annales de l'Institut Pasteur/Actualités, 1998, 9 (4), pp.361-371. ⟨10.1016/S0924-4204(99)80015-8⟩
Annales de l'Institut Pasteur / Actualités
Annales de l'Institut Pasteur / Actualités, 1998, 9 (4), pp.361-371. ⟨10.1016/S0924-4204(99)80015-8⟩
Annales de l'Institut Pasteur/Actualités, 1998, 9 (4), pp.361-371. ⟨10.1016/S0924-4204(99)80015-8⟩
Annales de l'Institut Pasteur / Actualités
Annales de l'Institut Pasteur / Actualités, 1998, 9 (4), pp.361-371. ⟨10.1016/S0924-4204(99)80015-8⟩
International audience; L'infection par le virus de Theiler a été successivement un modèle murin de la poliomyélite et de la sclérose en plaques. Après la présentation de ce qu'il est possible d'attendre d'un modèle animal, l'intérêt de la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc614a16ff60a516cd5ac6efcb93ebbf
https://hal.science/hal-02526326
https://hal.science/hal-02526326
Autor:
Philippe Monteyne, Jean-Paul Coutelier
Publikováno v:
The Journal of general virology. 75
Mouse infection with lactate dehydrogenase-elevating virus (LDV) leads to lifelong viraemia, despite the production of neutralizing antiviral antibodies. To test whether viral persistence correlated with the development of resistance to these antibod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2deaa073e49aa3125707eb2f03ed625
https://pubmed.ncbi.nlm.nih.gov/8176379
https://pubmed.ncbi.nlm.nih.gov/8176379